HIV molecular immunology database

 

Search CTL/CD8+ T-Cell Epitope Database

Found 1 matching record:

Displaying record number 62672

Download this epitope record as JSON.

HXB2 Location gp160(555-569)
gp41(44-58)
DNA(7887..7931)
gp160 Epitope Map
Author Location Env
Epitope LLRAIEQQHLLQLT Epitope Alignment
LLRAIEQQHLLQLT epitope logo
Species (MHC/HLA) human
Immunogen in vitro stimulation or selection, HIV-1 infection, vaccine
Experimental methods CD8 T-cell Elispot - IFNγ, CTL suppression of replication, Intracellular cytokine staining
Keywords HAART, ART, vaccine-induced immune responses, therapeutic vaccine, chronic infection, HIV reservoir/latency/provirus

Vaccine Details

Vaccine type modified vaccinia Ankara (MVA), polyepitope, recombinant protein
Vaccine strain A clade, B clade, multiple epitope immunogen, C clade, D clade
Vaccine component Env, Gag, Pol, Vif, other

Notes

References

Hancock2017 Gemma Hancock, Sara Morón-López, Jakub Kopycinski, Maria C. Puertas, Eleni Giannoulatou, Annie Rose, Maria Salgado, Emma-Jo Hayton, Alison Crook, Catharine Morgan, Brian Angus, Fabian Chen, Hongbing Yang, Javier Martinez-Picado, Tomas Hanke, and Lucy Dorrell. Evaluation of the Immunogenicity and Impact on the Latent HIV-1 Reservoir of a Conserved Region Vaccine, MVA.HIVconsv, in Antiretroviral Therapy-Treated Subjects. J. Int. AIDS. Soc., 20(1):21171, 19 May 2017. PubMed ID: 28537062. Show all entries for this paper.


Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health